|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 86, 858-863, Copyright © 1983 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
RB McElvein and G Zorn
The use of the carbon dioxide laser to remove intraluminal malignant
lesions of the trachea and main-stem bronchi is described. Forty-three
patients, 30 men and 13 women from 23 to 79 years of age, have received
from one to three laser treatments to provide an improved airway with
relief of major respiratory tract obstruction. There has been one
intraoperative death and there have been three immediate postoperative
deaths. Improvement in respiratory status has been accomplished in all
surviving patients and has persisted for from 1 to 36 months. The carbon
dioxide laser treatment does not cure cancer but does provide an improved
airway with low risk so that other treatment can be used. A major advantage
of this form of treatment is decreased bleeding and the ability to provide
an improved airway. The disadvantages are the necessity for general
anesthesia and expense of the equipment.
ARTICLES
Treatment of malignant disease in trachea and main-stem bronchi by carbon dioxide laser
This article has been cited by other articles:
![]() |
G. V. S. Parr, M. Unger, R. G. Trout, and W. G. Atkinson One Hundred Neodymium-YAG Laser Ablations of Obstructing Tracheal Neoplasms Ann. Thorac. Surg., October 1, 1984; 38(4): 374 - 381. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |